P&G Acquires Thorne for $3.8B | Vitamin Market Update

Procter & Gamble to Acquire Supplement Brand Thorne for $3.8 Billion in Cash 

SUMMERVILLE, SC, United States — August 12, 2026 — Procter & Gamble (P&G) has entered into a definitive agreement to acquire Thorne, a leading science-backed dietary supplement brand, for $3.8 billion in cash — marking one of the most significant corporate transactions in the vitamin market in recent years. P&G CEO Shailesh Jejurikar confirmed the deal on CNBC's Squawk on the Street, underscoring the consumer goods giant's strategic push into the high-growth health and wellness sector. 

P&G is acquiring Thorne from L Catterton, an LVMH-backed private equity firm. The transaction is expected to close later in 2026, subject to customary closing conditions and regulatory approvals. The deal reflects P&G's intent to expand its footprint in the premium supplement and wellness category, where consumer demand has demonstrated sustained and measurable growth. 

Thorne, headquartered in Summerville, South Carolina, is widely recognized for its practitioner-trusted, clinically validated formulations spanning vitamins, minerals, and specialty supplements. The brand has cultivated a strong reputation among healthcare professionals and health-conscious consumers, positioning it as a high-value strategic asset within P&G's expanding health care portfolio. 

According to data from Next Move Strategy Consulting, the global vitamin market was valued at USD 8.85 billion in 2023 and is projected to reach USD 13.30 billion by 2030, reflecting robust and sustained demand for premium nutritional products. P&G's acquisition of Thorne positions the company to capitalize directly on this expanding market opportunity. 

Key Highlights: 

• Procter & Gamble has agreed to acquire Thorne in an all-cash transaction valued at $3.8 billion 

• The seller is L Catterton, an LVMH-backed private equity firm with a significant stake in the wellness sector 

• The transaction is expected to close in calendar year 2026, pending customary regulatory approvals 

• The acquisition strategically expands P&G's presence in the premium health, wellness, and dietary supplement segment 

Analyst Insight: 

According to analysts at Next Move Strategy Consulting, P&G's $3.8 billion acquisition of Thorne reflects a broader and accelerating industry trend of large consumer goods conglomerates entering the premium supplement space to capture rising consumer health awareness. NMSC analysts note that with the global vitamin market projected to reach USD 13.30 billion by 2030, strategic M&A activity of this scale is expected to drive market consolidation, elevate product quality standards, and expand distribution reach across both clinical and direct-to-consumer channels. 

Industry Outlook: 

The P&G–Thorne transaction is poised to reshape competitive dynamics across the vitamin and dietary supplement industry. As major consumer goods companies deepen their investment in health and wellness, smaller supplement brands may face increased pressure to differentiate through clinical validation, personalized nutrition offerings, and direct-to-consumer engagement strategies. 

The deal also signals growing institutional confidence in the long-term growth trajectory of the global vitamin market, as demographic shifts, preventive health trends, and rising consumer spending on nutritional supplements continue to drive sector expansion. Regulatory scrutiny of the transaction will be closely monitored by industry stakeholders as the deal progresses toward its anticipated 2026 close. 

Source: Vitamin Retailer

For More Information: Download FREE Sample on Vitamin Market Report

Prepared By: Sanyukta Deb